59P Potential of AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alterations detected by a new NGS assay on liquid biopsy predictive of early response/resistance to hormonal therapy and CDK4/6 inhibitors
ESMO Open（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要